Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Klein, Eili Y ^a   Lewis, Ian A ^a   Jung, Christina ^a   Llinás, Manuel ^a   Levin, Simon A ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

Anti malarial drugs; Artemisinin; Counterfeit; Drug quality; Ghana

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; BENFLUMETOL; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; HERBACEOUS AGENT; PIPERAQUINE; TRIMETHOPRIM; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; COUNTERFEIT DRUG;

ADOLESCENT; ADULT; ARTICLE; CAREGIVER; CONTROLLED STUDY; DRUG COST; DRUG FORMULATION; DRUG QUALITY; DRUG SYNTHESIS; DRY POWDER; EDUCATIONAL STATUS; FEMALE; GHANA; HEALTH SURVEY; HELP SEEKING BEHAVIOR; HUMAN; HUMAN EXPERIMENT; IC 50; KNOWLEDGE; LICENCE; MALARIA; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PURCHASING; COMMERCIAL PHENOMENA; DRUG COMBINATION; DRUG EFFECT; MALARIA FALCIPARUM; PARASITOLOGY; PATIENT ATTITUDE; PHYSIOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; QUALITY CONTROL; STANDARD;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CAREGIVERS; CHILD, PRESCHOOL; COMMERCE; COUNTERFEIT DRUGS; DRUG THERAPY, COMBINATION; EDUCATIONAL STATUS; GHANA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALARIA, FALCIPARUM; PATIENT ACCEPTANCE OF HEALTH CARE; PLASMODIUM FALCIPARUM; QUALITY CONTROL;

EID: 84859382429     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-110     Document Type: Article

References (41)

1. The global distribution of clinical episodes of Plasmodium falciparum malaria. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, Nature 2005 434 214 217 10.1038/nature03342 15759000 (Pubitemid 40388051)
2. The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. Snow RW, Peshu N, Forster D, Mwenesi H, Marsh K, Trans R Soc Trop Med Hyg 1992 86 237 239 10.1016/0035-9203(92)90290-S 1412642
3. Antimalarial drug quality in the most severely malarious parts of Africa-A six country study. Bate R, Coticelli P, Tren R, Attaran A, PLoS One 2008 3 2132 10.1371/journal.pone.0002132 18461128 (Pubitemid 352025174)
4. Poor quality vital anti-malarials in Africa-an urgent neglected public health priority. Newton P, Green M, Mildenhall D, Plancon A, Nettey H, Nyadong L, Hostetler D, Swamidoss I, Harris G, Powell K, Timmermans A, Amin A, Opuni S, Barbereau S, Faurant C, Soong R, Faure K, Thevanayagam J, Fernandes P, Kaur H, Angus B, Stepniewska K, Guerin P, Fernandez F, Malar J 2011 10 352 10.1186/1475-2875-10-352 22152094
5. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ, PLoS Med 2005 2 100 10.1371/journal.pmed.0020100 15755195 (Pubitemid 40721074)
6. Saving lives, buying time: economics of malaria drugs in an age of resistance. Washington DC: Institute of Medicine, Arrow KJ, Panosian CB, Gelband H, 2004
7. Preventing antimalarial drug resistance through combinations. White NJ, Drug Resist Updat 1998 1 3 9 10.1016/S1368-7646(98)80208-2 17092790
8. Act now or later? Economics of malaria resistance. Laxminarayan R, Am J Trop Med Hyg 2004 71 187 195 15331837 (Pubitemid 39121322)
9. Benefits of using multiple first-line therapies against malaria. Boni M, Smith D, Laxminarayan R, Proc Natl Acad Sci USA 2008 105 14216 14221 10.1073/pnas.0804628105 18780786
10. Artemisinin resistance: current status and scenarios for containment. Dondorp AM, Yeung S, White L, Nguon C, Day NPJ, Socheat D, von Seidlein L, Nat Rev Micro 2010 8 272 280
11. Ensuring sustained ACT production and reliable artemisinin supply. Kindermans J-M, Pilloy J, Olliaro P, Gomes M, Malar J 2007 6 125 10.1186/1475-2875-6-125 17868471 (Pubitemid 47561490)
12. Artemisinin production in Artemisia annua: studies in planta and results of a novel delivery method for treating malaria and other neglected diseases. Weathers P, Arsenault P, Covello P, McMickle A, Teoh K, Reed D, Phytochem Rev 2011 10 173 183 10.1007/s11101-010-9166-0 21643453
13. Qinghaosu (Artemisinin): the price of success. White NJ, Science 2008 320 330 334 10.1126/science.1155165 18420924 (Pubitemid 351555649)
14. Prevalence and detection of counterfeit pharmaceuticals: a mini review. Fernandez FM, Green MD, Newton PN, Ind Eng Chem Res 2007 47 585 590
15. Manslaughter by fake artesunate in Asia-will Africa be next? Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJM, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NPJ, Greenwood BM, Nosten F, White NJ, PLoS Med 2006 3 197 10.1371/journal.pmed.0030197 16752952 (Pubitemid 43987814)
16. Counterfeit artesunate antimalarials in southeast Asia. Newton PN, Dondorp A, Green M, Mayxay M, White NJ, Lancet 2003 362 169 12867122 (Pubitemid 36831032)
17. Quality of artesunate tablets sold in pharmacies in Kumasi, Ghana. Ofori-Kwakye K, Asantewaa Y, Gaye O, Trop J Pharm Res 2008 7 1179 1184
18. Anti-malarial drug quality in Lagos and Accra-a comparison of various quality assessments. Bate R, Hess K, Malar J 2010 9 157 10.1186/1475-2875-9-157 20537190
19. United States Pharmacopeia Drug Quality and Information Program, Survey of the Quality of Selected Antimalarial Medicines Circulating in Madagascar, Senegal, and Uganda: November 2009 Rockville, Md: The United States Pharmacopeial Convention 2010
20. Quality control of active ingredients in artemisinin-derivative antimalarials within Kenya and DR Congo. Atemnkeng MA, De Cock K, Plaizier-Vercammen J, Trop Med Int Health 2007 12 68 17207150
21. A Nationwide survey of the quality of antimalarials in retail outlets in Tanzania. Kaur H, Goodman C, Thompson E, Thompson K-A, Masanja I, Kachur SP, Abdulla S, PLoS One 2008 3 3403 10.1371/journal.pone.0003403 18923672
22. Substandard anti-malarial drugs in Burkina Faso. Tipke M, Diallo S, Coulibaly B, Störzinger D, Hoppe-Tichy T, Sie A, Müller O, Malar J 2008 7 95 10.1186/1475-2875-7-95 18505584 (Pubitemid 351814584)
23. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. Ioset J-R, Kaur H, PLoS One 2009 4 7270 10.1371/journal.pone.0007270 19789707
24. World Health Organization, Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa Geneva: World Health Organization 2011
25. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Caudron JM, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J, Trop Med Int Health 2008 13 1062 1072 10.1111/j.1365-3156.2008. 02106.x 18631318
26. Maternal education and child survival in developing countries: the search for pathways of influence. Cleland JG, van Ginneken JK, Soc Sci Med 1988 27 1357 1368 10.1016/0277-9536(88)90201-8 3070762 (Pubitemid 19000644)
27. Guidelines for field surveys of the quality of medicines: a proposal. Newton PN, Lee SJ, Goodman C, Fernandez FM, Yeung S, Phanouvong S, Kaur H, Amin AA, Whitty CJM, Kokwaro GO, Lindegårdh N, Lukulay P, White LJ, Day NPJ, Green MD, White NJ, PLoS Med 2009 6 1000052
28. Fast and accurate method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. Lewis IA, Schommer SC, Hodis B, Robb KA, Tonelli M, Westler WM, Sussman MR, Markley JL, Anal Chem 2007 79 9385 9390 10.1021/ac071583z 17985927 (Pubitemid 350276316)
29. Combining two-dimensional diffusion-ordered nuclear magnetic resonance spectroscopy, imaging desorption electrospray ionization mass spectrometry, and direct analysis in real-time mass spectrometry for the integral investigation of counterfeit pharmaceuticals. Nyadong L, Harris GA, Balayssac SP, Galhena AS, Malet-Martino M, Martino R, Parry RM, Wang MD, Fernández FM, Gilard VR, Anal Chem 2009 81 4803 4812 10.1021/ac900384j 19453162
30. Analytical challenges in drug counterfeiting and falsification-The NMR approach. Holzgrabe U, Malet-Martino M, J Pharm Biomed Anal 2011 55 679 687 10.1016/j.jpba.2010.12.017 21232896
31. rNMR: open source software for identifying and quantifying metabolites in NMR spectra. Lewis IA, Schommer SC, Markley JL, Magn Reson Chem 2010 47 123 S126
32. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Le Nagard H, Vincent C, Mentré F, Le Bras J, Comput Methods Programs Biomed 2011 104 10 18 10.1016/j.cmpb.2010.08.003 20828858
33. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Eastman RT, Fidock DA, Nat Rev Micro 2009 7 864 874
34. Counterfeit anti-infective drugs. Newton PN, Green MD, Fernández FM, Day NPJ, White NJ, Lancet Infect Dis 2006 6 602 613 10.1016/S1473-3099(06) 70581-3 16931411
35. Does price reveal poor-quality drugs? Evidence from 17 countries. Bate R, Jin GZ, Mathur A, J Health Econ 2011
36. Comparison of the bioequivalence of three oral formulations of dihydroartemisinin based on ex vivo blood schizontocidal activities against Plasmodium falciparum. Kongthaisong M, Na-bangchang K, Mungthin M, Sinchaipanid N, Tan-ariya P, AmJTrop Med Hyg 2004 71 703 710 (Pubitemid 40075617)
37. A global subsidy: key to affordable drugs for malaria? Laxminarayan R, Gelband H, Health Aff (Millwood) 2009 28 949 961 10.1377/hlthaff.28.4.949
38. Validation of quantitative NMR. Malz F, Jancke H, J Pharm Biomed Anal 2005 38 813 823 10.1016/j.jpba.2005.01.043 15893442 (Pubitemid 41115787)
39. Method performance and validation for quantitative analysis by 1H and 31P NMR spectroscopy. Applications to analytical standards and agricultural chemicals. Maniara G, Rajamoorthi K, Rajan S, Stockton GW, Anal Chem 1998 70 4921 4928 10.1021/ac980573i 21644675 (Pubitemid 28553160)
40. Applications of quantitative 1H- and 13C-NMR spectroscopy in drug analysis. Pieters LAC, Vlietinck AJ, J Pharm Biomed Anal 1989 7 1405 1417 10.1016/0731-7085(89)80145-1 2490526 (Pubitemid 20253562)
41. Quantitative 1H NMR: development and potential of a method for natural products analysis. Pauli GF, Jaki BU, Lankin DC, J Nat Prod 2004 68 133 149